Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation.

William H Herman; Shahnaz Shahinfar; George W Carides; Erik J Dasbach; William C Gerth; Charles M Alexander; John R Cook; William F Keane; Barry M Brenner

doi:10.2337/diacare.26.3.683

Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation.

Identifier:nobleid.org/w1/20260515/1A033CDF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1A033CDF.svg?ark=w1%2F20260515%2F1A033CDF)](https://nobleid.org/work/w1/20260515/1A033CDF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation.

Identifier:nobleid.org/w1/20260515/1A033CDF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/1A033CDF.svg?ark=w1%2F20260515%2F1A033CDF)](https://nobleid.org/work/w1/20260515/1A033CDF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work